Kyle Jackson

Kyle Jackson began their career as a Process Engineer III at Sanofi Genzyme in 2012, where they worked until February 2018. In February 2018, they joined Partner Therapeutics as a Process Engineer, and they are still currently employed in this role.

Kyle Jackson earned a Bachelor of Science (BS) degree in Cell/Cellular and Molecular Biology from the University of Washington. Kyle then went on to complete a Master of Business Administration (MBA) degree at Seattle University in 2005.